Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tizanidine for Postoperative Urinary Retention
NCT06258785Phase 3Completed
- Sponsor
- Endeavor Health
- Start
- Sep 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tizanidine in postoperative urinary retention (POUR), sponsored by Endeavor Health. Started Sep 2024; status: completed.
02
Drugs
tizanidine
03
Conditions
postoperative urinary retention (POUR)
Beyond the preview
Go deeper on NCT06258785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06258785.